Vaneltix Pharma Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 6

  • Investments
  • 1

Vaneltix Pharma General Information

Description

Developer of therapies designed to treat urological disorders and women's health conditions. The company offers a combination product of heparin and alkalinized lidocaine, an enhanced formulation of a bladder pain drug, and regenerative therapies for bladder wall linings, enabling healthcare providers to provide immediate relief for patients suffering from interstitial cystitis and pelvic pain.

Contact Information

Formerly Known As
Urigen N.A, Valentis, Urigen Pharmaceuticals, MEGABIOS
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 317 George Street
  • Suite 400
  • New Brunswick, NJ 08901
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Former Stock Listing
URGP
Corporate Office
  • 317 George Street
  • Suite 400
  • New Brunswick, NJ 08901
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaneltix Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vaneltix Pharma‘s full profile, request access.

Request a free trial

Vaneltix Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapies designed to treat urological disorders and women's health conditions. The company offers a combin
Drug Discovery
New Brunswick, NJ
4 As of 2025

Boston, MA
 

Stevenage, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vaneltix Pharma Competitors (27)

One of Vaneltix Pharma’s 27 competitors is Vertex Pharmaceuticals, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
NeRRe Therapeutics Venture Capital-Backed Stevenage, United Kingdom
Supernus Formerly VC-backed Rockville, MD
UCB Corporation Brussels, Belgium
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
You’re viewing 5 of 27 competitors. Get the full list »

Vaneltix Pharma Patents

Vaneltix Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018251806-A1 Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability Active 12-Apr-2017
AU-2018251806-B2 Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability Active 12-Apr-2017
CA-3061891-A1 Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability Pending 12-Apr-2017
EP-3609483-A1 Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability Pending 12-Apr-2017
EP-3609483-A4 Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability Pending 12-Apr-2017 A61K31/727
To view Vaneltix Pharma’s complete patent history, request access »

Vaneltix Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vaneltix Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vaneltix Pharma‘s full profile, request access.

Request a free trial

Vaneltix Pharma Acquisitions (1)

Vaneltix Pharma’s most recent deal was a Merger/Acquisition with Valentis (Pharmaceuticals). The deal was made on 16-Jul-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Valentis (Pharmaceuticals) 16-Jul-2007 Merger/Acquisition Drug Discovery
To view Vaneltix Pharma’s complete acquisitions history, request access »

Vaneltix Pharma FAQs

  • When was Vaneltix Pharma founded?

    Vaneltix Pharma was founded in 1997.

  • Where is Vaneltix Pharma headquartered?

    Vaneltix Pharma is headquartered in New Brunswick, NJ.

  • What is the size of Vaneltix Pharma?

    Vaneltix Pharma has 4 total employees.

  • What industry is Vaneltix Pharma in?

    Vaneltix Pharma’s primary industry is Drug Discovery.

  • Is Vaneltix Pharma a private or public company?

    Vaneltix Pharma is a Private company.

  • What is Vaneltix Pharma’s current revenue?

    The current revenue for Vaneltix Pharma is .

  • How much funding has Vaneltix Pharma raised over time?

    Vaneltix Pharma has raised $5.38M.

  • Who are Vaneltix Pharma’s investors?

    Platinum-Montaur Life Sciences, Valentis (Pharmaceuticals), and University of California, San Diego have invested in Vaneltix Pharma.

  • Who are Vaneltix Pharma’s competitors?

    Vertex Pharmaceuticals, NeRRe Therapeutics, Supernus, UCB, and ACADIA Pharmaceuticals are some of the 27 competitors of Vaneltix Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process